Stay updated with breaking news from Jamie christensen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JMP Securities lowered shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) from an outperform rating to a market perform rating in a research note published on Monday, Marketbeat reports. Several other equities research analysts have also recently commented on the company. Citigroup upgraded Mirati Therapeutics from a neutral rating to a buy rating and cut […] ....
Scotiabank upgraded shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) from an underperform rating to a sector perform rating in a research report sent to investors on Monday morning, MarketBeat reports. The firm currently has $58.00 target price on the biotechnology company’s stock. Other research analysts also recently issued research reports about the company. JMP […] ....
Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fourteen analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the […] ....
James Christensen, Ph.D., and Nancy Whiting, Pharm.D., join Board of DirectorsGeorge Demetri, M.D., to serve as first member of Clinical Advisory BoardSAN DIEGO (BUSINESS WIRE) Boundless Bio, a clinical stage, next-generation precision oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver. ....
Mirati Therapeutics (NASDAQ:MRTX) Shares Down 3.7% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.